Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 468, doi. 10.1038/cgt.2012.20
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2012 AND VI 19 AND IP 7
Results: 8
1
2
Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 499, doi. 10.1038/cgt.2012.24
- By:
- Publication type:
- Article
3
Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 443, doi. 10.1038/cgt.2012.14
- By:
- Publication type:
- Article
4
Peptide targeting of adenoviral vectors to augment tumor gene transfer.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 476, doi. 10.1038/cgt.2012.23
- By:
- Publication type:
- Article
5
MicroRNA silencing improves the tumor specificity of adenoviral transgene expression.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 451, doi. 10.1038/cgt.2012.16
- By:
- Publication type:
- Article
6
IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 460, doi. 10.1038/cgt.2012.17
- By:
- Publication type:
- Article
7
Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 489, doi. 10.1038/cgt.2012.18
- By:
- Publication type:
- Article
8
Interferon-β lipofection I. Increased efficacy of chemotherapeutic drugs on human tumor cells derived monolayers and spheroids.
- Published in:
- Cancer Gene Therapy, 2012, v. 19, n. 7, p. 508, doi. 10.1038/cgt.2012.27
- By:
- Publication type:
- Article